GL331-induced disruption of cyclin B1/CDC 2 complex and inhibition of CDC 2 kinase activity

Apoptosis

Volumn 1, Issue 3, 1996, Pages 213-217

  Huang, T S ^a,b   Yang, W K ^a   Whang Peng, J ^a  

^a ACADEMIA SINICA   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

CDC 2; Cell cycle; Cyclin b1; Etoposide (vp 16); GL331

Indexed keywords

EID: 0000147198     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01321105     Document Type: Article

References (7)

1. Wang Z-Q, Kuo Y-H, Schnur D, et al. Antitumor agents. 113. New 4β-arylamino derivatives of 4′-O-demethylepipodophyllotoxic and related compounds as potent inhibitors of human DNA topoisomerase II. J Med Chem 1990; 33: 2660-2665.
2. Huang T-S, Shu C-H, Shih Y-L, et al. Protein tyrosine phosphatase activities are involved in apoptotic cancer cell death induced by GL331, a new homolog of etoposide. Cancer Lett 1996; in press.
3. Sullivan DM, Chow K-C, Ross WE. Topoisomerase II mediated mechanisms of drug resistance. In: Kessel D, ed. Resistance to Antineoplastic Drugs. Boca Raton, FL: CRC Press, 1989: 281-292.
4. Chang J-Y, Han F-S, Liu S-Y, Wang Z-Q, Lee K-H, Cheng Y-C. Effect of 4β-arylamino derivatives of 4′-O-demethylepipodophyllotoxm on human DNA topoisomerase II, tubulin polymerization, KB cells, and their resistant variants. Cancer Res 1991; 51: 1755-1759.
5. Clio SJ, Kashiwada Y, Bastow KF, Cheng Y-C, Lee K-H. Antitumor Agents. 164. Podophenazine, 2″, 3″-dichloropodophenazine, benzopodophenazine, and their 4β-p-nitroaniline derivatives as novel DNA topoisomerase II inhibitors. J Med Chem 1996; 39: 1396-1402.
6. Bodley AL, Liu LF. Topoisomerases as novel targets for cancer chemotherapy. Biotechnology 1988; 6: 1315-1319.
7. Kautmann SH. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 1989; 49: 5870-5878.